Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON22844Not yet recruiting
Randomised, double-blind trial of dronabinol, sponsored by University Medical Center Utrecht. Primary endpoint: Blood oxygen level dependent signal. Planned start Apr 2008; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON22844.